Literature DB >> 12645974

Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement.

Michael I Greenberg1, Robert G Hendrickson.   

Abstract

Intrathecal baclofen is used as a muscle relaxant and antispasmodic in cases of spasticity resulting from central nervous system trauma. The baclofen withdrawal syndrome may include hyperthermia, tachycardia, hypertension, seizures, altered mental status, and psychomotor agitation. We report a case in which the removal of a baclofen pump lead tothe development of severe withdrawal symptoms despite oral baclofen replacement therapy. In order to avoid the development of withdrawal, adequate doses of GABA agonist agents should be administered immediately prior to, and following, baclofen pump removal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645974     DOI: 10.1081/clt-120018277

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  12 in total

1.  Intrathecal baclofen withdrawal syndrome following posterior spinal fusion for neuromuscular scoliosis: a case report.

Authors:  Pedro Fernandes; Lori Dolan; Stuart L Weinstein
Journal:  Iowa Orthop J       Date:  2008

2.  Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: a case report.

Authors:  Anthony F Pizon; Frank Lovecchio
Journal:  J Med Toxicol       Date:  2007-12

3.  Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission.

Authors:  Bret D Alvis; Christopher M Sobey
Journal:  Neurohospitalist       Date:  2016-03-14

4.  Dexmedetomidine for acute baclofen withdrawal.

Authors:  Simon Morr; Christopher M Heard; Veetai Li; Renée M Reynolds
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

Review 5.  Acute intrathecal baclofen withdrawal: a brief review of treatment options.

Authors:  James C Ross; Aaron M Cook; Gary L Stewart; Brenda G Fahy
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

6.  In Support of Initial Parenteral Medical Management of Intrathecal Baclofen Withdrawal in Spasticity Patients.

Authors:  Brian L LaRowe; Vicki M Nussbaum
Journal:  J Pharm Technol       Date:  2021-08-12

Review 7.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Intrathecal pumps.

Authors:  Shawn Belverud; Alon Mogilner; Michael Schulder
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 9.  Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension.

Authors:  Andrew King; Mirjana Dimovska; Luke Bisoski
Journal:  Curr Hypertens Rep       Date:  2018-02-24       Impact factor: 5.369

Review 10.  Baclofen therapeutics, toxicity, and withdrawal: A narrative review.

Authors:  Jia W Romito; Emily R Turner; John A Rosener; Landon Coldiron; Ashutosh Udipi; Linsey Nohrn; Jacob Tausiani; Bryan T Romito
Journal:  SAGE Open Med       Date:  2021-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.